Dr. Aliya Qayyum, MD

Dr. Qayyum practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Qayyum's NPI, 1568419224, was assigned on May 28, 2006. Dr. Qayyum graduated from Charing Cross and Westminister Medical School in 1991. Dr. Qayyum holds Florida license ME148037.

Dr. Qayyum's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612. Dr. Qayyum also practices at H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc., 10920 McKinley Dr, Tampa, FL 33612.

Dr. Qayyum's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Qayyum to 1 more breast imaging center, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Qayyum practices, 4 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Qayyum's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dr. Qayyum is board certified in diagnostic radiology by the American Board of Radiology. Dmand AI has Dr. Qayyum's licenses on file in 3 states: Florida, California and Texas.

CMS data shows 998 Medicare services from Dr. Qayyum across 10 procedure codes in 2024, for 638 Medicare patients. Medicare paid $54,923 for them.

CMS counts 638 Medicare patients who saw Dr. Qayyum in 2024. The largest group is 65 to 74, with 305 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Qayyum's median patient age at 68, with 50% women.

In 2018, Dr. Qayyum wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $52 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Qayyum for performance year 2024, reported as part of a group. Dr. Qayyum accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 141 papers to Dr. Qayyum, published from 2003 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Magnetic Resonance Imaging, Tomography, X-Ray Computed and Diagnosis, Differential. Dr. Qayyum has published most often in AJR Am J Roentgenol. Dr. Qayyum's most frequent co-authors are Benjamin M. Yeh, MD, Bonnie N. Joe, MD and Emily M. Webb, MD.

Dmand AI links Dr. Qayyum to 1 clinical trial. Conditions studied include Carcinoma, Hepatocellular and Liver Neoplasms. Open Payments lists research payments to Dr. Qayyum that name 1 trial.

CMS Open Payments shows 10 general payments to Dr. Qayyum from 2 drug and device companies from 2017 to 2019. Travel and lodging make up the largest share, 89% of the total. GE Healthcare paid the most, $3,054. It also lists 6 research payments totaling $18,280 in 2025, naming 1 clinical trial.

Dmand AI lists 6 awards for Dr. Qayyum, most recently Mentorship Recognition in 2008.

Dr. Qayyum graduated from Charing Cross and Westminister Medical School in 1991. Dr. Qayyum is a member of AAWR, ACR, ARRS, Houston Radiology Society, ISMRM and RSNA.

Dr. Qayyum is in network with 2 carriers, including Excellus BlueCross BlueShield and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.